Maria A Parker1, Andrea H Weinberger2, Andrea C Villanti3. 1. Indiana University School of Public Health, Department of Epidemiology & Biostatistics, Bloomington, IN, United States. Electronic address: map2@iu.edu. 2. Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, United States; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, United States. Electronic address: andrea.weinberger@yu.edu. 3. Vermont Center on Behavior & Health, University of Vermont, Burlington, VT, United States. Electronic address: andrea.villanti@uvm.edu.
Abstract
BACKGROUND: The prevalence of cigarette smoking is more than two times higher among individuals with versus without opioid misuse and/or opioid use disorders (OUD). Overall, smoking cessation has increased over time although it is unknown whether it has similarly increased for those with opioid misuse or OUD. The current study examined cigarette quit ratios from 2002 to 2018 among US individuals with and without opioid misuse or OUD. METHODS: Data came from the National Survey on Drug Use and Health, a yearly cross-sectional survey of US civilians 12 years or older. Annual quit ratios (i.e., proportion of former smokers among lifetime-smokers) were estimated from 2002 to 2018. Logistic regression tested time trends in quit ratios by opioid misuse/OUD. RESULTS: Past-month smoking prevalence was much higher for persons with versus without opioid misuse (64.6 % versus 25.7 %) and OUD (73.3 % versus 26.0 %). In 2018, quit ratios for individuals with opioid misuse (18.0 %) or OUD (10.0 %) were less than half of those without opioid misuse (48.3 %) or OUD (48.1 %). After adjusting for background characteristics, the quit ratio did not change over time among individuals with opioid misuse or OUD in contrast to an increase in quit ratios for those without opioid misuse or OUD. For those without opioid misuse or OUD, males had higher quit ratios than females. CONCLUSIONS: Cigarette quit ratios remain dramatically lower among those with opioid misuse or OUD. Public health and clinical attention are needed to increase cessation and reduce smoking consequences for individuals with opioid misuse and OUD.
BACKGROUND: The prevalence of cigarette smoking is more than two times higher among individuals with versus without opioid misuse and/or opioid use disorders (OUD). Overall, smoking cessation has increased over time although it is unknown whether it has similarly increased for those with opioid misuse or OUD. The current study examined cigarette quit ratios from 2002 to 2018 among US individuals with and without opioid misuse or OUD. METHODS: Data came from the National Survey on Drug Use and Health, a yearly cross-sectional survey of US civilians 12 years or older. Annual quit ratios (i.e., proportion of former smokers among lifetime-smokers) were estimated from 2002 to 2018. Logistic regression tested time trends in quit ratios by opioid misuse/OUD. RESULTS: Past-month smoking prevalence was much higher for persons with versus without opioid misuse (64.6 % versus 25.7 %) and OUD (73.3 % versus 26.0 %). In 2018, quit ratios for individuals with opioid misuse (18.0 %) or OUD (10.0 %) were less than half of those without opioid misuse (48.3 %) or OUD (48.1 %). After adjusting for background characteristics, the quit ratio did not change over time among individuals with opioid misuse or OUD in contrast to an increase in quit ratios for those without opioid misuse or OUD. For those without opioid misuse or OUD, males had higher quit ratios than females. CONCLUSIONS: Cigarette quit ratios remain dramatically lower among those with opioid misuse or OUD. Public health and clinical attention are needed to increase cessation and reduce smoking consequences for individuals with opioid misuse and OUD.
Authors: William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu Journal: Drug Alcohol Depend Date: 2018-11-26 Impact factor: 4.492
Authors: Judith Parsells Kelly; Suzanne F Cook; David W Kaufman; Theresa Anderson; Lynn Rosenberg; Allen A Mitchell Journal: Pain Date: 2008-03-14 Impact factor: 6.961
Authors: Philip H Smith; Andrew J Bessette; Andrea H Weinberger; Christine E Sheffer; Sherry A McKee Journal: Prev Med Date: 2016-07-26 Impact factor: 4.018
Authors: Joanna M Streck; Susan Regan; Jordan Neil; Sara Kalkhoran; Priya S Gupta; Benjamin Bearnot; Faith K Coker; Kelly M Kalagher; Elyse R Park; Sarah Wakeman; Nancy A Rigotti Journal: Nicotine Tob Res Date: 2022-06-15 Impact factor: 5.825
Authors: Maria A Parker; Whitney S Cordoba-Grueso; Joanna M Streck; Renee D Goodwin; Andrea H Weinberger Journal: Drug Alcohol Depend Date: 2021-09-20 Impact factor: 4.492
Authors: Stephen T Higgins; Jennifer W Tidey; Stacey C Sigmon; Sarah H Heil; Diann E Gaalema; Dustin Lee; John R Hughes; Andrea C Villanti; Janice Y Bunn; Danielle R Davis; Cecilia L Bergeria; Joanna M Streck; Maria A Parker; Mollie E Miller; Michael DeSarno; Jeff S Priest; Patricia Cioe; Douglas MacLeod; Anthony Barrows; Catherine Markesich; Roxanne F Harfmann Journal: JAMA Netw Open Date: 2020-10-01